SCHEMBL20168686

SCHEMBL20168686

O=C(C1CCN(c2nccc(-c3nnn[nH]3)n2)CC1)N1N=CC[C@H]1c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25767762 0.85 RIPK1 (0.77) RIPK1
SCHEMBL20166099 0.85 RIPK1 (0.77) RIPK1
SCHEMBL20168819 0.84 RIPK1 (0.67) RIPK1
SCHEMBL20168823 0.84 RIPK1 (0.67) RIPK1
SCHEMBL20166047 0.82 RIPK1 (0.68) RIPK1
SCHEMBL20166328 0.82 RIPK1 (0.68) RIPK1
SCHEMBL18248368 0.81 RIPK1 (1.00) RIPK1
SCHEMBL18248207 0.81 RIPK1 (1.00) RIPK1
SCHEMBL20168812 0.81 RIPK1 (0.78) RIPK1
SCHEMBL20168814 0.81 RIPK1 (0.78) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541813-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-09-25 EP disclosed
WO-2018092089-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-05-24 WO disclosed